Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)

References

• Geller AI, Shehab N, Weidle NJ, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;373:1531–1540.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Attipoe S, Travis J, et al. Caffeine content of dietary supplements consumed on military bases. JAMA Intern Med. 2013;173:592–594.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8:357–369.
   PubMed Web of Science ®Google Scholar
• Archer JR, Dargan PI, Lostia AM, et al. Running an unknown risk: a marathon death associated with the use of 1,3-dimethylamylamine (DMAA). Drug Test Anal. 2015;7:433–438.
   PubMed Web of Science ®Google Scholar
• Eliason MF, Eichner A, Cancio A, et al. Case reports: death of active duty soldiers following ingestion of dietary supplements containing 1, 3-dimethylamylamine (DMAA). Military Med. 2012;177:1455–1459.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Zeijlon R, Nardin R, et al. Hemorrhagic stroke probably caused by exercise combined with a sports supplement containing β-methylphenyl-ethylamine (BMPEA): a case report. Ann Intern Med. 2015;162:879–880.
   PubMed Web of Science ®Google Scholar
• Pawar RS, Grundel E, Fardin-Kia AR, et al. Determination of selected biogenic amines in Acacia rigidula plant materials and dietary supplements using LC-MS/MS methods. J Pharm Biomed Anal. 2014;88:457–466.
   PubMed Web of Science ®Google Scholar
• Kwiatkowska D, Wójtowicz M, Jarek A, et al. N, N-dimethyl-2-phenylpropan-1-amine – new designer agent found in athlete urine and nutritional supplement. Drug Test Anal. 2015;7:331–335.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Travis JC, Venhuis BJ. A methamphetamine analog (N, α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test Anal. 2014;6:805–807.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Avula B, Venhuis B, et al. Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA. Drug Test Anals. 2017;9:135–142.
   PubMed Web of Science ®Google Scholar
• Cohen PA. DMAA as a dietary supplement ingredient. Arch Intern Med. 2012;172:1038–1039.
   PubMed Web of Science ®Google Scholar
• DMAA in dietary supplements. United States Food and Drug Administration website. [Internet]; [cited 2017 Jun 6]. Available from: https://www.fda.gov/food/dietarysupplements/productsingredients/ucm346576.htm.
   Google Scholar
• Cohen PA, Travis JC, Venhuis BJ. A synthetic stimulant never tested in humans, 1, 3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements. Drug Test Anal. 2015;7:83–87.
   PubMed Web of Science ®Google Scholar
• DMBA in dietary supplements. United States Food and Drug Administration website. [Internet]; [cited 2017 Jun 6]. Available from: https://www.fda.gov/food/dietarysupplements/productsingredients/ucm444719.htm.
   Google Scholar
• Rohrmann E, Shonle HA. Amino alkanes as pressor substances. J Am Chem Soc. 1944;66:1516–1520.
   Google Scholar
• Swanson EE, Chen KK. Comparison of pressor action of aliphatic amines. J Pharmacol Exp Ther. 1946;88:10–13.
   PubMed Web of Science ®Google Scholar
• Marsh DF. The comparative pharmacology of the isomeric heptylamines. J Pharmacol Exp Ther. 1948;94:225–231.
   PubMed Web of Science ®Google Scholar
• Murphy Q, O’Brien GS, Meek WJ. The effects of aliphatic sympathomimetic amines on cardiac automatic tissue in dogs under cyclopropane. Anesthesiology. 1950;11:437–442.
   PubMed Web of Science ®Google Scholar
• Marsh DF, Howard A, Herring DA. The comparative pharmacology of the isomeric nitrogen methyl substituted heptylamines. J Pharm Exp Ther 1951;103:325–329.
   PubMed Web of Science ®Google Scholar
• Singhuber J, Zhu M, Prinz S, et al. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol. 2009;126:18–30.
   PubMed Web of Science ®Google Scholar
• Li JS, Chen M, Li ZC. Identification and quantification of dimethylamylamine in geranium by liquid chromatography tandem mass spectrometry. Anal Chem Insights. 2012;7:47–58.
   PubMedGoogle Scholar
• Fleming HL, Ranaivo PL, Simone PS. Analysis and confirmation of 1, 3-DMAA and 1, 4-DMAA in geranium plants using high performance liquid chromatography with tandem mass spectrometry at ng/g concentrations. Anal Chem Insights. 2012;7:59–78.
   PubMedGoogle Scholar
• Ademiluyi AO, Ogunsuyi OB, Oboh G. Alkaloid extracts from Jimson weed (Datura stramonium L.) modulate purinergic enzymes in rat brain. NeuroToxicol. 2016;56:107–117.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li B, Wang Y, et al. Lipopeptides, a novel protein, and volatile compounds contribute to the antifungal activity of the biocontrol agent Bacillus atrophaeus CAB-1. Appl Microbiol Biotechnol. 2013;97:9525–9534.
   PubMed Web of Science ®Google Scholar
• Li H-Y, Li S-N, Wang S-X, et al. Degradation of lignocellulose in corn straw by Bacillus amyloliquefaciens MN-8. Yingyong Shengtai Xuebao. 2015;26:1404–1410.
   Google Scholar
• Li H-Y, Li S-N, Wang S-X, et al. Screening, identification of lignin-degradating Bacillus MN-8 and its characteristics in degradation of maize straw lignin. Zhongguo Nongye Kexue. 2014;47:324–333.
   Google Scholar
• Eskay’s Oralator. In Physicians’ Desk Reference 1949. 3rd ed. Rutherford, NJ: Medical Economics Inc; 1949. p. 476.
   Google Scholar
• US Food and Drug Administration. Drugs approved 1938-present (including supplements) (Listed by approval date). May 1, 1990:1439.
   Google Scholar
• Ordinal® forte. In: Med Mschr: Zeits Allgem Med Ther. Vol. 29. 1975;. p 473.
   Google Scholar
• Kiese M, Schüssler W. Neue spezialitäten. Klin Wochenschr. 1967;45:551.
   Google Scholar
• Göde J. Der bronchospasmolytische Effekt unter der Behandlung mit Ambredin. Therap Gegenw. 1958;97:106–107.
   PubMedGoogle Scholar
• Ordinal retard. In Muller NF, Dessing RP, editors. European Drug Index, 2nd ed. Amsterdam: Elsevier; 1992. p. 868.
   Google Scholar
• Alles GA. Comparative physiological actions of aliphatic secondary carbin-ammonium salts. I.α-methylalkyl-ammonium compounds. Univ Cal Publ Pharm. 1946;2:183–203.
   Google Scholar
• Fellows EJ. The pharmacology of 2-amino-6-methylheptane. J Pharmacol Exp Ther. 1947;90:351–358.
   PubMed Web of Science ®Google Scholar
• Marsh DF, Herring DA. The comparative pharmacology of the isomeric chain methyl substituted heptylamines. J Pharm Exp Ther. 1950;98:300–304.
   PubMed Web of Science ®Google Scholar
• Semenza F. Pharmacology of 2-methyl-6-aminoheptane. Boll Soc Ital Biol Sperim. 1951;27:354–357.
   PubMedGoogle Scholar
• Marsh DF, Herring DA. The comparative pharmacology of the hydroxy and methyl derivatives of 6-methyl-2-heptylamine. J Pharm Exp Ther. 1951;103:178–186.
   PubMed Web of Science ®Google Scholar
• Ota Y. Pharmacological studies on alklaminoheptane deriavatives. IV. Blood pressor, antispasmodic, and capillary permeability inhibiting action of N-alkyl-1,5-dimethylhexylamine derivatives. Yakugaku Zasshi. 1961;81:403–407.
   Google Scholar
• Oelkers HA. Pharmacology of 2-amino-6-methylheptane (+)-camphor-10-sulfonate. Arzneim-Forsch. 1967;17:25–28.
   PubMedGoogle Scholar
• Becker KH, Doerner J. Circulation studies with 2-amino-6-methylheptane (+)-camphor-10-sulfonate in dogs. Arzneim-Forsch. 1967;17:28–32.
   PubMedGoogle Scholar
• Tschirkov F, Groß P, Krause E, et al. Haemodynamische wirkung von 2-amino-6-methylheptan-(+)-campher-10-sulfonat. Arch Kreislaufforschung. 1971;65:162–169.
   PubMedGoogle Scholar
• Petry R, Kolb KH. Studies on the intestinal absorption of sympathomimetic substances in man. Arzneim-Forsch 1973;23:1535–1538.
   PubMed Web of Science ®Google Scholar
• Trieb G, Nusser E. Untersuchungen zur Kreislaufwirkung von Ordinal® retard bei Patienten mit hypotoner (statisch labiler) Blutdruckregulationsstörung. Herz/Kreislauf. 1974;6:681–688.
   Google Scholar
• Charlier R, Philippot E. Action of three aliphatic amines on the respiratory volume. Arch Int Pharmacodyn Ther. 1950;82:243–246.
   PubMedGoogle Scholar
• Charlier R. Pharmacology of 2-amino-6-methyl-heptane. Arch Int Pharmacodyn Ther. 1951;85:144–151.
   PubMedGoogle Scholar
• Wei X-Y, Xu H-X, Yang X-J, et al. Analysis of essential oil of Forsythia suspense (Thunb.) Vahl. By GC-MS and its antioxidant activities. Shaanxi Shifan Daxue Xuebao. 2010;38:70–74.
   Google Scholar
• Zhao YY, Dai Y, Cui XM, et al. Chemical constituents of Aconitum kusnezoffii volatile oil. Zhongchengyao. 2007;29:588–591.
   Google Scholar
• Al-Wathnani H, Ara I, Tahmaz RR, et al. Bioactivity of natural compounds isolated from cyanobacteria and green algae against human pathogenic bacteria and yeast. J Med Plants Res. 2012;6:3425–3433.
   Google Scholar
• Sadasivan SL, Nair BR. GC-MS analysis in two species of Biophytum DC. (Oxalidaceae). J Pharm Res. 2014;8:466–473.
   Google Scholar
• Xu Y, Liu Y, Jiang C, et al. Determination of volatile compounds in turbot (Psetta maxima) during refrigerated storage by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J Sci Food Agric. 2014;94:2464–2471.
   PubMed Web of Science ®Google Scholar
• Arkhipov A, Sirdaarta J, Matthews B, et al. Metabolomic profiling of Kigelia africana extracts with anti-cancer activity by high resolution tandem mass spectroscopy. Pharmacog Comm 2014;4:10–32.
   Google Scholar
• Xu YX, Liu Y, Song ST, et al. Analysis of volatile compounds in turbot by SPME with different extraction fibers. Shipin Gongy Keji. 2013;34:90–97.
   Google Scholar
• Dong ZJ, Li DM, Li SW, et al. Preparation of barbecue shrimp flavoring essence by Maillard reaction from low-valued sea shrimp and its analysis by GC-MS and electronic nose. Shipin Gongye Kej. 2013;34:101–107.
   Google Scholar
• Avula B, Wang M, Sagi S, et al. Identification and quantification of 1,3-dimethylbutylamine (DMBA) from Camellia sinensis tea leaves and dietary supplements. J Pharm Biomed Anal. 2015;115:159–168.
   PubMed Web of Science ®Google Scholar
• Cohen PA. DMAA as a dietary ingredient-reply. JAMA Intern Med. 2013;173:595.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Maller G, DeSouza R, et al. Presence of banned drugs in dietary supplements following FDA recalls. JAMA. 2014;312:1691–1693.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Bloszies C, Yee C, et al. An amphetamine isomer whose efficacy and safety in humans has never been studied, β-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test Anal. 2016;8:328–333.
   PubMed Web of Science ®Google Scholar
• Operation Supplement Safety. Dietary supplement products containing DMAA. [Internet]; [cited 2017 Jun 8]. Available from: http://hprc-online.org/dietary-supplements/files/dmaa-list-master-pdf.
   Google Scholar
• Eichner S, Maguire M, Shea LA, et al. Banned and discouraged-use ingredients found in weight loss supplements. J Am Pharm Assoc. 2016;56:538–543.
   Google Scholar